Webcast CME

Biologic Therapies VII: Precision Medicine in the Biologic Era


RJ Fasenmyer Annual Lectureship
Cytokine Profiles in Health and Disease –
What Can They Inform Us?

Print this Content

Release Date:   August 7, 2017
Expiration Date:   August 7, 2019

Estimated Time of Completion:   45 minutes

Description

Biologic Therapies VII: Precision Medicine in the Biologic Era online series brings together world leaders in immune-based therapies and addresses cutting-edge translational immunology and the latest data on biologic therapeutics.

RJ Fasenmyer Annual Lectureship Cytokine Profiles in Health and Disease – What Can They Inform Us? will review key advances and lessons from the last decade of rheumatoid arthritis therapeutics. The webcast will also cover translational research models and their impact on the pathogenesis of rheumatoid arthritis and the advent of biomarkers.

Learning Objectives

  1. Discuss the key advances and lessons from the last decade of rheumatoid arthritis therapeutics.
  2. Describe how translational research models can inform the pathogenesis of rheumatoid arthritis, considering the various stages of the disease over time, and the advent of biomarkers.

Target Audience

The online series is designed for rheumatologists, allergists/immunologists, dermatologists, internal medicine physicians, and associated allied health practitioners, including nurse practitioners, nurses, and physician assistants interested in or using biologic therapeutics for autoimmune and inflammatory disorders.

Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

Activity Directors and Faculty

Activity Directors

Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
R.J. Fasenmyer Chair of Clinical Immunology
Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH

M. Elaine Husni, MD, MPH
Director, Arthritis and Musculoskeletal Treatment Center
Vice Chair, Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH

Faculty

Iain McInnes, FRCP, PhD, FRSE, FMedSci
Muirhead Professor of Medicine
ARUK Professor of Rheumatology
Director of Institute of Infection Immunity and Inflammation
College of Medical, Veterinary and Life Sciences
University of Glasgow
Glasgow, Scotland

CME Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

Disclosures

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty have indicated that they may have a relationship which, in the context of their presentation, could be perceived as a potential conflict of interest:


Leonard H. Calabrese, DO
  AbbVie Pharmaceuticals; Bristol Myers Squibb;
Genentech/ Roche; Janssen
Consulting; Teaching and Speaking
  GlaxoSmithKline; Pfizer, Inc.; UCB Consulting
  Crescendo Teaching and Speaking
M. Elaine Husni, MD, MPH
  AbbVie Pharmaceuticals; Genentech; Janssen Consulting
  Amgen; Bristol-Myers Squibb; Genzyme/Sanofi; Lilly, Regeneron Consulting;
Membership on advisory committee or review panels
  Novartis Pharmaceuticals Consulting; Teaching and Speaking
  Pfizer, Inc. Membership on advisory committee or review panels
Iain McInnes, FRCP, PhD, FRSE, FmedSci
  AbbVie Pharmaceuticals; Janssen; MSD; Novartis Consulting
  Bristol-Myers Squibb Co.; Pfizer, Inc.; UCB Consulting;
Independent contractor (including contracted research)
  Roche Pharmaceuticals Consulting; Membership on advisory committee or review panels

 

The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for partial support of this activity from:

AbbVie, Inc.
Amgen, Inc.
Bristol-Myers Squibb Co.
Celgene Corporation
Crescendo Bioscience, Inc.
Genentech
Janssen Scientific Affairs, LLC
Novartis Pharmaceuticals Corporation
UCB, Inc.

This CME activity was produced by the Cleveland Clinic Foundation Center for Continuing Education
and the R.J. Fasenmyer Center for Clinical Immunology.